Health and Fitness Health and Fitness
Tue, October 25, 2011
[ Tue, Oct 25th 2011 ] - Market Wire
Dr. Reddyas Q2 FY12 Financial Results
[ Tue, Oct 25th 2011 ] - Market Wire
Exelixis Appoints Executive Vice President and Chief Commercial Officer
[ Tue, Oct 25th 2011 ] - Market Wire
DaVita Announces Government Inquiry
Mon, October 24, 2011
[ Mon, Oct 24th 2011 ] - Market Wire
Given Imaging Announces New Studies Showing PillC .. an Detect and Monitor Small Bowel Crohn's Disease
[ Mon, Oct 24th 2011 ] - Market Wire
Given Imaging Announces Results From Multiple PillCam(R) COLON Studies Presented at UEGW 2011
[ Mon, Oct 24th 2011 ] - Market Wire
Given Imaging Announces New Studies Highlighting .. solution Manometry Testing for Conditions Resulti
[ Mon, Oct 24th 2011 ] - Market Wire
Basilea announces conclusion of BAL30072 phase I multiple ascending dose study
[ Mon, Oct 24th 2011 ] - Market Wire
Law Office of Brodsky & Smith, LLC Announces Investigation of HealthSpring, Inc.
[ Mon, Oct 24th 2011 ] - Market Wire
Law Firm Brower Piven Announces Investigation of HealthSpring, Inc.
[ Mon, Oct 24th 2011 ] - Market Wire
HealthSouth to Present at Lazard Capital Markets Healthcare Conference
[ Mon, Oct 24th 2011 ] - Market Wire
Spherix Announces Results from New Preclinical St .. es Significant Reductions in Cholesterol, Fat Dep
[ Mon, Oct 24th 2011 ] - Market Wire
Skilled Healthcare Expands Hospice Presence in Southern California and Phoenix Markets
[ Mon, Oct 24th 2011 ] - Market Wire
Anthera Announces Third Quarter 2011 Financial Report and Conference Call
[ Mon, Oct 24th 2011 ] - Market Wire
Pacific Safety Products Inc. Reports Fourth Quarter and Fiscal 2011 Year End Results
[ Mon, Oct 24th 2011 ] - Market Wire
Orthofix International Announces its Support for the SMISS Prospective Data Registry
[ Mon, Oct 24th 2011 ] - Market Wire
Teleflex Incorporated Signs New Three-Year Agreements with Novation
[ Mon, Oct 24th 2011 ] - Market Wire
Blinded Results From Low Dose Cohort of Phase II SHIGATEC Trial Presented at IDSA Annual Meeting
[ Mon, Oct 24th 2011 ] - Market Wire
Merck Announces Presentation of Phase III Investi .. ULERA (mometasone furoate and formoterol fumarate
[ Mon, Oct 24th 2011 ] - Market Wire
Gilead and GlobeImmune Announce License and Colla .. Therapeutic Vaccine Products for Treatment of Ch
[ Mon, Oct 24th 2011 ] - Market Wire
ZELTIQ Aesthetics, Inc. Completes Initial Public Offering
[ Mon, Oct 24th 2011 ] - Market Wire
For The Earth Adds Another Retailer for Continued Growth in 2012
[ Mon, Oct 24th 2011 ] - Market Wire
The Briscoe Law Firm and Powers Taylor, LLP Announce Investigation of Adolor Corporation
[ Mon, Oct 24th 2011 ] - Market Wire
RedFin Network Emerges Stronger After Hypercom(R) SPS End-of-Life
[ Mon, Oct 24th 2011 ] - Market Wire
Rigrodsky & Long, P.A. Announces Investigation of Adolor Corporation
[ Mon, Oct 24th 2011 ] - Market Wire
Lakeland Industries to Present at the 6th Annual .. ular Research "Best of the Uncovereds" Conference
[ Mon, Oct 24th 2011 ] - Market Wire
The Briscoe Law Firm and Powers Taylor, LLP Announce Investigation of K-V Pharmaceutical Company
[ Mon, Oct 24th 2011 ] - Market Wire
The Briscoe Law Firm and Powers Taylor, LLP Announce Investigation of HealthSpring, Inc.
[ Mon, Oct 24th 2011 ] - Market Wire
Harwood Feffer LLP Announces Investigation of HealthSpring Inc.
[ Mon, Oct 24th 2011 ] - Market Wire
Harwood Feffer LLP Announces Investigation of Adolor Corp.
[ Mon, Oct 24th 2011 ] - Market Wire
Array BioPharma to Report Financial Results for t .. First Quarter of Fiscal 2012 on October 31, 2011

Array BioPharma to Report Financial Results for the First Quarter of Fiscal 2012 on October 31, 2011


Published on 2011-10-24 10:05:37 - Market Wire
  Print publication without navigation


BOULDER, Colo.--([ BUSINESS WIRE ])--Array BioPharma Inc. (Nasdaq:ARRY) will report financial results for the first quarter of fiscal 2012 on Monday, October 31, 2011, and will hold a conference call on Tuesday, November 1, 2011 at 9:00 a.m. eastern time to discuss these results. Robert E. Conway, Chief Executive Officer, and Michael Carruthers, Chief Financial Officer, will lead the call.

Conference Call Information

Date:

 Tuesday, November 1, 2011

Time:

 9:00 a.m. eastern time

Toll-Free:

 800.260.8140

Toll:

 617.614.3672

Pass Code:

 85947414

Webcast & Conference Call Slides:

[ http://investor.arraybiopharma.com/phoenix.zhtml?c=123810&p=irol-irhome ]

A replay of the call will be available as a webcast on [ www.arraybiopharma.com ]

About Array BioPharma

Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small-molecule drugs to treat patients afflicted with cancer and inflammatory diseases. Our proprietary drug development pipeline includes clinical candidates that are designed to regulate therapeutically important target proteins and are aimed at significant unmet medical needs. For more information on Array, please go to [ www.arraybiopharma.com ].

Contributing Sources